USD/CHF Price Forecast: Bulls clash at 100-day SMA, eyes on 0.7950
The USD/CHF advanced by 0.24% on Tuesday as geopolitical tensions remained high, even after reports of a one-month ceasefire, according to Al Arabiya, citing Israeli Channel 12. At the time of writing, the pair trades at 0.7881 after bouncing off daily lows of 0.7859.
USD/CHF Price Forecast: Technical Outlook
The technical picture shows that USD/CHF is neutral to bullish, even though it remains below the 200-day Simple Moving Average (SMA) at 0.7949.
Momentum, as measured by the Relative Strength Index (RSI), shows that buyers are gaining traction, though if they want to test higher prices, they must clear key resistance levels on the upside.
If USD/CHF clears the 100-day SMA of 0.7893, expect a test of the 0.7900 figure. Once cleared, the next area of interest will be the 200-day SMA at 0.7949, followed by the 0.8000 threshold.
On the bearish side, if USD/CHF tumbles below the March 23 daily low of 0.7834, it could open the door to a challenge of the 50-day SMA key support at 0.7798. On further weakness, a retracement towards the March 10 swing low of 0.7748 is on the cards.
USD/CHF Price Chart – Daily
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Arista Networks (ANET.US) Q3 Conference Call: CEO Says There Are Over 100 Ethernet AI Clients Entering the AI Supercycle, First Guidance for 2027 Revenue at $18.5 Billion
Arista Networks released its financial results for the third quarter of 2026 ended September 30 and held a conference call after the market closed on the same day.
Democrats lead strongly in the midterms; US stock futures plunge, the US dollar falls, US Treasuries rise, and Asian stock markets come under pressure.
Preliminary vote counts for the 2026 U.S. midterm elections show strong momentum for the Democratic Party, with market bets on a "blue wave" sweeping both chambers of Congress increasing sharply.
Citi: Diversified business growth of Amgen (AMGN.US) offsets decline in Enbrel revenue; future outlook depends on execution of R&D pipeline
Citi believes that Amgen's upward revision of its full-year guidance has further strengthened market confidence in its commercialization capabilities. However, its forward valuation multiples are increasingly dependent on whether its R&D pipeline can meet expectations.
Super Micro Computer (SMCI.US) Q1 Earnings Call: Gross margin declined quarter-on-quarter does not mean AI business is unprofitable, accounts receivable turnover days decreased
Super Micro Computer released its fiscal year 2027 first quarter results after the market close on Tuesday and held an earnings conference call.
Crypto prices
More
